Model‐free scoring system for risk prediction with application to hepatocellular carcinoma study

Model‐free scoring system for risk prediction with application to hepatocellular carcinoma study IntroductionGenomic medical research has generated a large number of candidate biomarkers that have potential use in the early‐phase detection and prognosis of many diseases. Compared to the conventional approach based on single biomarker, simultaneously using multiple biomarkers can substantially improve the sensitivity and accuracy of early detection of diseases (Sidransky, ; Etzioni et al., ). Multiple biomarker‐based scoring systems, such as the International Prognostic Scoring System (IPSS) (Greenberg et al., ), WHO Prognostic Scoring System (WPSS), and Revised International Prognostic Scoring System (IPSS‐R) (Greenberg et al., ), have played fundamental roles in the treatment decision‐making process. For example, multiple biomarkers have been used to guide treatment decisions for Myelodysplastic syndromes (MDS), a heterogeneous group of myeloid disorders. IPSS or IPSS‐R can play a crucial role in differentiating between patients at high risk of disease progression, for whom a more aggressive treatment may be justified, and patients with a minor risk of disease progression, for whom a more conservative treatment may be preferable.Although developing scoring systems for risk prediction has been an active research area, the vast majority of them have focused on binary outcomes (e.g., developing disease or not). Su and Liu () considered linear discriminant analysis by maximizing the area under http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Biometrics Wiley

Model‐free scoring system for risk prediction with application to hepatocellular carcinoma study

Loading next page...
 
/lp/wiley/model-free-scoring-system-for-risk-prediction-with-application-to-nW5spmw4Gc
Publisher
Wiley Subscription Services, Inc., A Wiley Company
Copyright
© 2018, The International Biometric Society
ISSN
0006-341X
eISSN
1541-0420
D.O.I.
10.1111/biom.12750
Publisher site
See Article on Publisher Site

Abstract

IntroductionGenomic medical research has generated a large number of candidate biomarkers that have potential use in the early‐phase detection and prognosis of many diseases. Compared to the conventional approach based on single biomarker, simultaneously using multiple biomarkers can substantially improve the sensitivity and accuracy of early detection of diseases (Sidransky, ; Etzioni et al., ). Multiple biomarker‐based scoring systems, such as the International Prognostic Scoring System (IPSS) (Greenberg et al., ), WHO Prognostic Scoring System (WPSS), and Revised International Prognostic Scoring System (IPSS‐R) (Greenberg et al., ), have played fundamental roles in the treatment decision‐making process. For example, multiple biomarkers have been used to guide treatment decisions for Myelodysplastic syndromes (MDS), a heterogeneous group of myeloid disorders. IPSS or IPSS‐R can play a crucial role in differentiating between patients at high risk of disease progression, for whom a more aggressive treatment may be justified, and patients with a minor risk of disease progression, for whom a more conservative treatment may be preferable.Although developing scoring systems for risk prediction has been an active research area, the vast majority of them have focused on binary outcomes (e.g., developing disease or not). Su and Liu () considered linear discriminant analysis by maximizing the area under

Journal

BiometricsWiley

Published: Jan 1, 2018

Keywords: ; ; ; ; ;

There are no references for this article.

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Unlimited reading

Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.

Stay up to date

Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.

Organize your research

It’s easy to organize your research with our built-in tools.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

Monthly Plan

  • Read unlimited articles
  • Personalized recommendations
  • No expiration
  • Print 20 pages per month
  • 20% off on PDF purchases
  • Organize your research
  • Get updates on your journals and topic searches

$49/month

Start Free Trial

14-day Free Trial

Best Deal — 39% off

Annual Plan

  • All the features of the Professional Plan, but for 39% off!
  • Billed annually
  • No expiration
  • For the normal price of 10 articles elsewhere, you get one full year of unlimited access to articles.

$588

$360/year

billed annually
Start Free Trial

14-day Free Trial